In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
A new study published in eClinicalMedicine analyzed 19 studies on monkeypox, which included 7,553 reported cases, among which there were 555 hospitalizations. The meta-analysis suggests monkeypox patients have a 14.1% hospitalization rate.
A report last week from the European Food Safety Authority (EFSA) suggests steps could be taken to limit the spread of antimicrobial resistance (AMR) in food-producing animals during transportation.
Today during a Clinician Outreach and Communication Activity call, officials from the Centers for Disease Control and Prevention (CDC) recommended that pregnant women, breastfeeding women, and children who have been exposed to monkeypox be tested promptly if they show symptoms.
Late last week, the Centers for Disease Control and Prevention (CDC) reported a further rise in US flu activity, particularly in the southeast and south central regions, along with another variant H3N2 (H3N2v) flu case, this time in a Michigan resident who had indirect exposure to swine at an agricultural fair.
A 5-year-old girl in northern Vietnam tested positive for H5 and is seriously ill.
A multicenter observational study found that the use of antibiotics after nonemergent surgery in children varied widely across US hospitals but was not correlated with skin site infection (SSI) in children, US researchers reported yesterday in JAMA Surgery.
Previous non-Omicron SARS-CoV-2 infection was tied to a 44% lower risk of Omicron reinfection and 81% lower odds of related hospitalization, which was further improved by one, two, or three mRNA COVID-19 vaccine doses (86%, 94%, and 97%, respectively), according to a study published late last week in JAMA Network Open.
COVID-19 vaccination may protect pregnant women and their fetuses against virus-related placentitis (inflammation of the placenta) and stillbirth, concludes a review study published today in the American Journal of Obstetrics & Gynecology. The research will also be presented next week at ID Week in Washington, DC.
A US study of almost 17,000 patients finds modest two-dose Pfizer COVID vaccine effectiveness (VE) against hospitalization and emergency department (ED) admission for Omicron BA.1 (the original Omicron variant) and the BA.2 subvariant, but three-dose VE was 79% and 71% for hospitalization, respectively, and 72% and 21% for ED visits.
